Mandadi Tilak
EVP, Chief Exp & Tech Officer
Mandadi Tilak has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: May 11, 2026.
On the most recent filing, Mandadi Tilak is listed as EVP, Chief Exp & Tech Officer at CVS HEALTH Corp. Inside the rolling window, Mandadi Tilak reported no open-market purchases and 1 open-market sale totaling $6.2M in CVS.
Companies traded
Other insiders at CVS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Mandadi Tilak made?
Mandadi Tilak has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Mandadi Tilak trade?
Mandadi Tilak has filed SEC Form 4 disclosures for 1 company, including CVS.
When was Mandadi Tilak's most recent SEC Form 4 filing?
Mandadi Tilak's most recent SEC Form 4 filing on Tracefour is dated May 11, 2026.
What is Mandadi Tilak's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Mandadi Tilak is listed as EVP, Chief Exp & Tech Officer.
What is Mandadi Tilak's total buy and sell value in the current window?
Inside the rolling retention window, Mandadi Tilak bought $0 and sold $6.2M based on SEC Form 4 filings.
What was Mandadi Tilak's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 69,551 CVS shares on 2026-05-08, worth $6.2M, per SEC Form 4 filings.